MAPS - Multidisciplinary Association for Psychedelic Studies
MAPS bulletin - volume xvii - number 2 - Autumn 2007
< Return to Bulletin Archive Index

Letter From the Editor, Jag Davies

jag@maps.org

MAPS' organizational strategy prioritizes clinical research because cold, hard science is required to lay the foundation for the broad changes that we are aiming to generate. Although clinical research may persuade the FDA that psychedelics and marijuana are safe and have legitimate therapeutic applications, the re-integration of legal contexts for the use of psychedelics in our society can only reach its full potential if there is an honest, human side to the story as well.

The human stories are already there, waiting to be told. Furthermore,for some people in certain contexts, psychedelics are already somewhat integrated into their culture or society. Yet, thanks to prohibition and the associated stigmas and misunderstandings surrounding psychedelics, many potentially valuable stories and lessons are never shared.

One of the more insidious aspects of psychedelic prohibition is that it can trap its critics and civil disobedients in oppositional dualisms. As by-products of society and open to the subtle power of suggestion, even psychedelic users can't help but take some of society's implicit assumptions for granted.

That has been my experience, at least. Shortly after my eighteenth birthday, I had my first "experience," with a friend at a lush botanical park. In retrospect, I was not as well-educated or prepared as I could have been. For one thing, my primary motivation was "fun." While it was indeed fun at times, it was also one of the most startling, blissful, self-introspective, frightening, emotionally unsettling, surreal and thought-provoking experiences of my life. My expectation of mere "fun," as one might imagine, was somewhat counter-productive.

Another effect of prohibition is that it influences more than just laws; it also institutionalizes other forms of discrimination. Growing up in the1980s and 90s in a mostly poor, multi-racial neighborhood in Miami, I not only saw the catastrophic effects of the "War on Drugs" firsthand, but I also gleaned from the city's racial and ethnic tensions that changing a law or policy - such as prohibiting race-based prejudice and segregation - does not necessarily change ingrained behaviors and assumptions. If psychedelics were made completely legal tomorrow, more subtle forms of harmful discrimination would undoubtedly persist.

For MAPS to achieve its long-term goals of re-integrating the legal use of psychedelics and marijuana into our society, itis imperative that we facilitate cultural understanding, in addition to scientific knowledge. While it may be practical for MAPS to identify specific clinical indications for which psychedelic-assisted therapy is safe and efficacious, MAPS also believes that with proper preparation and guidance, psychedelics can help improve the quality of life for "normal," healthy people without a diagnosed psychiatric disorder. The topic of self-discovery cuts to the heart of this.

On behalf of the MAPS staff, thank you to the thoughtful, open, and courageous individuals that contributed to this special issue.

 

 
< Return to Table of Contents: - Autumn 2007 "Psychedelics and Self Discovery"
 
Bulletin Archive Index
'
Winter 2008 Vol. 18, No. 1 Special Edition: Technology and Psychedelics
Winter 2007 Vol. 17, No. 3 MAPS 06-07 Fiscal Yearly Report
Autumn 2007 Vol. 17, No. 2 Special Edition: Psychedelics and Self-Discovery
Spring/Summer 2007 Vol. 17, No. 1 The Chrysalis Stage
Winter 2006-7 Vol. 16, No. 3 Low Maintenance/High Performance
Autumn 2006 Vol. 16, No. 2 Technologies of Healing
Spring 2006 Vol. 16, No. 1 MAPS' 20th Anniversary
Winter 2005 Vol. 15, No. 3 MAPS final year as a teenager
Summer 2005 Vol. 15, No. 2 Israel Conference: MDMA/PTSD Research
Spring 2005 Vol. 15, No. 1 Accelerating flow of work and time
Autumn 2004 Vol. 14, No. 2 Rites of Passage: Kids and Psychedelics
Summer 2004 Vol. 14, No. 1 10 stamps and $250,000
Winter 2003 Vol. 13, No. 2 Holy Fire
Spring 2003 Vol. 13, No. 1 60th Anniversary of the Discovery of LSD
Autumn 2002 Vol. 12, No. 3 Vision
Summer 2002 Vol. 12, No. 2 "From celebration to frustration, and back again."
Spring 2002 Vol. 12, No. 1 Sex, Spirit & Psychedelics 2002
Autumn 2001 Vol. 11, No. 2 "In the future, it will be called Despair."
Spring 2001 Vol. 11, No. 1 "A Tidal Wave of Ecstasy!"
Autumn 2000 Vol. 10, No. 3 Creativity 2000
Summer 2000 Vol. 10, No. 2 Endings and Beginnings
Spring 2000 Vol. 10, No. 1 Making History in Slow Motion
Winter 1999/00 Vol. 9, No. 4 To the Ends of the Earth for MDMA Research...
Autumn 1999 Vol. 9, No. 3 MAPS' long-standing efforts to conduct...
Summer 1999 Vol. 9, No. 2 MAPS has come full circle...
Spring 1999 Vol. 9, No. 1 Patience, persistence and passion
Winter 1998/99 Vol. 8, No. 4 One of special pleasures of directing MAPS...
Autumn 1998 Vol. 8, No. 3 The Ayahuasca Issue (with Hofmann interview)
Summer 1998 Vol. 8, No. 2 Emotionally Powerful Anecdotes...
Spring 1998 Vol. 8, No. 1 Death Has a Way of Focusing One's Attention
Autumn 1997 Vol. 7, No. 4 Celebration is in Order
Summer 1997 Vol. 7, No. 3 Time Horizons
Spring 1997 Vol. 7, No. 2 Synchronicity
Winter 1996/97 Vol. 7, No. 1 Learning to Crawl
Autumn 1996 Vol. 6, No. 4 An Invitation for Dialogue
Summer 1996 Vol. 6, No. 3 Budding Research
New Year 1996 Vol. 6, No. 2 Sending Down Roots
Autumn 1995 Vol. 6, No. 1 Baby Steps
Summer 1995 Vol. 5, No. 4 Opportunity Amidst Obstacles
Winter 1994/95 Vol. 5, No. 3 Clinical Trials and Tribulations
Autumn 1994 Vol. 5, No. 2 Building Towards Clinical Trials
Summer 1994 Vol. 5, No. 1 Politics and Protocols: In Search of a Balance
Spring 1994 Vol. 4, No. 4 Laying the Groundwork
Winter 1993/94 Vol. 4, No. 3 A Time of Tests
Summer 1993 Vol. 4, No. 2 So Close Yet So Far
Spring 1993 Vol. 4, No. 1 Remembrance and Renewal
Winter 1992/93 Vol. 3, No. 4 Forging New Alliances
Summer 1992 Vol. 3, No. 3 Building on Common Ground
Spring 1992 Vol. 3, No. 2 Small Steps, Gradual Progress, New Opportunities
Winter 1991/92 Vol. 3, No. 1 The Rekindling of a Thousand Points of Light
Summer 1991 Vol. 2, No. 2 MDMA protocol development with cancer patients
Winter 1990/91 Vol. 2, No. 1 MAPS' Swiss pharmacologically-assisted psychotherapy conference
Autumn 1990 Vol. 1, No. 3 What and Who is MAPS?
Summer 1989 Vol. 1, No. 2 Switzerland Leads the Way
Summer 1988 Vol. 1, No. 1 MDMA can become a legal medicine